Skip to main content
. 2011 Nov 1;17(11):CR609–CR617. doi: 10.12659/MSM.882045

Table 2.

Transplant-related characteristics of renal transplant recipients according to CMV serostatus >1 year after transplantation.

CMV serostatus >1 year after transplantation P
Negative Seroconverted Seropositive
n (%) 174 (29) 152 (25) 280 (46)
Donor demographics
Age (years) 35.9±15.4 34.8±14.9 38.7±15.6 0.02
Male, n (%) 98 (56) 82 (54) 148 (53) 0.8
Renal allograft function
Serum creatinine concentration (ìmol/L) 136 [112–162] 129 [111–170] 134 [114–166] 0.8
Creatinine clearance (mL/min) 66.5±21.2 59.6±21.3 60.5±23.5 0.007
Proteinuria (g/24hr) 0.2 [0.0–0.4] 0.2 [0.0–0.5] 0.2 [0.0–0.5] 0.7
Prior dialysis duration (mo) 25 [1247] 26 [1529] 29 [16–53] 0.09
Transplantation type, n (%)
Postmortem donor 137 (79) 134 (88) 232 (83) 0.06
Living donor 33 (19) 15 (10) 35 (12)
Combined transplantation 4 (2) 3 (2) 13 (5)
Number of previous transplants, n (%)
0 163 (94) 134 (88) 245 (88) 0.01
1 or more 11 (6) 18 (12) 35 (12)
Acute rejection, n (%) 77 (44) 77 (51) 118 (42) 0.2
Immunosuppressive era, n (%)
from 1968 to January 1989 30 (17) 65 (43) 17 (6) <0.0001
from January 1989 to February 1993 19 (11) 17 (11) 54 (20)
from March 1993 to May 1997 42 (24) 32 (21) 83 (29)
from May 1997 to date 83 (48) 38 (25) 126 (45)
Immunosuppresion
Prednisolone dose, (mg/day) 10.0 [7.5–10.0] 10.0 [7.5–10.0] 10.0 [7.5–10.0] 0.04
Calcineurine inhibitor, n (%) 140 (81) 94 (62) 241 (86) P=0.04
Cyclosporin, n (%) 112 (65) 81 (53) 197 (70) 0.5
Trough–level (μg/L) 114 [82–140] 101 [75–128] 108 [80–143] 0.2
Tacrolimus, n (%) 28 (16) 13 (9) 44 (16) 0.5
Trough–level (μg/L) 8 [611] 10 [711] 9 [610] 0.7
Proliferation inhibitor, n (%)
Azathioprine or Mycophenolate mofetil 133 (76) 107 (70) 208 (74) 0.5

Values are presented as mean ±standard deviation, median (interquartile range) or percentages. P for trend was calculated with χ-square, Kruskal Wallis test and linear regression for dichotomous, ordinal and continuous variables, respectively. Skewed data were normalized by logarithmic transformation in all analyses.